NasdaqGS - Nasdaq Real Time Price USD
Century Therapeutics, Inc. (IPSC)
As of 10:56 AM EDT. Market Open.
Major Holders
| Breakdown | |
|---|---|
| 28.46% | % of Shares Held by All Insider |
| 61.14% | % of Shares Held by Institutions |
| 85.47% | % of Float Held by Institutions |
| 93 | Number of Institutions Holding Shares |
Top Institutional Holders
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5.41M | Jun 30, 2024 | 6.39% | 8,440,162 |
| VR Adviser, LLC | 5.39M | Jun 30, 2024 | 6.36% | 8,407,243 |
| Casdin Capital, LLC | 5.19M | Jun 30, 2024 | 6.13% | 8,097,189 |
| Boxer Capital, LLC | 4.9M | Jun 30, 2024 | 5.79% | 7,646,500 |
| FMR, LLC | 2.95M | Jun 30, 2024 | 3.48% | 4,602,435 |
| Blackrock Inc. | 2.9M | Jun 30, 2024 | 3.42% | 4,517,156 |
| Vanguard Group Inc | 1.73M | Jun 30, 2024 | 2.04% | 2,702,127 |
| DAFNA Capital Management, LLC | 1.7M | Jun 30, 2024 | 2.01% | 2,658,601 |
| Octagon Capital Advisors LP | 1.33M | Jun 30, 2024 | 1.57% | 2,080,493 |
| Adage Capital Partners GP L.L.C. | 1.32M | Jun 30, 2024 | 1.56% | 2,063,491 |
Top Mutual Fund Holders
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| iShares Russell 2000 ETF | 1.04M | Sep 30, 2024 | 1.23% | 1,619,588 |
| Vanguard Extended Market Index Fund | 785.57k | Jun 30, 2024 | 0.93% | 1,225,490 |
| Fidelity Growth Company Fund | 747.75k | Aug 31, 2024 | 0.88% | 1,166,494 |
| Vanguard Total Stock Market Index Fund | 628.42k | Jun 30, 2024 | 0.74% | 980,341 |
| Fidelity Small Cap Index Fund | 478.23k | Jul 31, 2024 | 0.56% | 746,041 |
| Fidelity Growth Company K6 Fund | 467.62k | Aug 31, 2024 | 0.55% | 729,482 |
| iShares Russell 2000 Value ETF | 417.67k | Sep 30, 2024 | 0.49% | 651,558 |
| Federated Hermes Kaufmann Fund | 267.75k | Jul 31, 2024 | 0.32% | 417,682 |
| Fidelity Extended Market Index Fund | 266.74k | Aug 31, 2024 | 0.31% | 416,106 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 143.8k | Jun 30, 2024 | 0.17% | 224,327 |
Related Tickers
GLUE Monte Rosa Therapeutics, Inc.
5.41
-1.99%
MGX Metagenomi, Inc.
1.9100
-2.55%
ARTV Artiva Biotherapeutics, Inc.
11.34
-6.82%
IKNA Ikena Oncology, Inc.
1.6800
-1.75%
NKTX Nkarta, Inc.
4.4000
+3.29%
SANA Sana Biotechnology, Inc.
4.1050
-2.96%
FATE Fate Therapeutics, Inc.
3.0850
-4.49%
ERAS Erasca, Inc.
2.7600
-5.15%
LYEL Lyell Immunopharma, Inc.
1.1150
-4.70%
KYTX Kyverna Therapeutics, Inc.
5.36
-4.96%